Updated July 2026 · 9 min read
Part of the ICU Pharmacology Hub — browse every related guide in one place.
Medical Disclaimer: This article is general educational information for licensed clinicians and students, not medical advice or a substitute for your institution's protocols or a provider's orders. Always follow your facility's policies and a provider's orders.
Two of the oldest names in ICU sedation, still hung side by side every day — but they behave nothing alike once the infusion has been running for a while. Propofol turns off almost as fast as it turns on. Midazolam keeps working long after you stop it, especially in the patients who are sick the longest. That single difference in how they clear drives most of the modern preference, and it's the thing to understand first.
Both work on the GABA-A receptor, the brain's main inhibitory switch — which is why both sedate. But the pharmacokinetics diverge sharply. Propofol is highly lipophilic with rapid redistribution and metabolism, so its effect tracks the infusion almost in real time. Midazolam is also lipophilic but is metabolized in the liver to an active metabolite (1-hydroxymidazolam) that is renally cleared — so in kidney or liver dysfunction, and after days of infusion loading up the fat stores, the drug and its active metabolite pile up and the patient stays sedated long after the drip is off.
| Propofol | Midazolam (Versed) | |
|---|---|---|
| Class | GABA-A agonist (non-benzo) | Benzodiazepine |
| Onset | Very fast (~1–2 min) | Fast (~2–5 min) |
| Offset after drip | Fast — even after days | Slow, unpredictable; accumulates |
| Active metabolite | No | Yes (renally cleared) |
| Hemodynamics | Hypotension, mild brady | More hemodynamically stable |
| Amnesia | Yes | Strong amnesia |
| Delirium risk | Lower than benzos | Higher — benzo-associated delirium |
| Signature hazard | Propofol infusion syndrome (PRIS) | Accumulation, prolonged sedation |
Propofol's great advantage is control. Because it clears so fast, you can lighten sedation on demand — the daily "sedation vacation," neuro exams, and spontaneous breathing trials that shorten ventilator days all depend on a drug that lets the patient wake up predictably. That's why the PADIS sedation guidelines steer toward non-benzodiazepine agents like propofol (or dexmedetomidine) over benzodiazepines for most mechanically ventilated adults: lighter, more arousable sedation is associated with less delirium and shorter time on the vent. See the full propofol guide for titration detail, and our Precedex vs propofol comparison for the other modern option.
Midazolam isn't obsolete — it's just no longer the default. Its strong amnestic effect and hemodynamic stability make it valuable when propofol's hypotension is intolerable, in deeply unstable patients, and in situations that call for a benzodiazepine specifically: status epilepticus, severe alcohol withdrawal, and refractory agitation where benzo mechanism is the point. It's also the more stable choice during transport or procedures in a fragile patient. The trade is the back end: after a long infusion, especially with renal or hepatic dysfunction, the wake-up is slow and unpredictable, which undercuts daily awakening trials and lengthens ventilator time — and benzodiazepines are independently linked to ICU delirium. The midazolam guide covers dosing and the accumulation problem in depth.
For routine sedation of a ventilated adult where you want to wake the patient daily, propofol (or dexmedetomidine) is favored — fast off, less delirium. When the patient can't tolerate propofol's blood-pressure drop, needs deep amnesia, is in status epilepticus or serious withdrawal, or is being moved and needs rock-steady hemodynamics, midazolam has the edge. Long-running benzodiazepine infusions are deliberately minimized now precisely because of the accumulation and delirium problems. Neither drug provides analgesia — an "analgesia-first" approach with a separate opioid is standard, since untreated pain masquerades as agitation and drives up sedation requirements. The ICU sedation & analgesia guide ties the whole strategy together.
For both: a validated sedation scale (RASS) titrated to a light target unless deep sedation is specifically ordered, continuous hemodynamic and respiratory monitoring, and a paired plan for analgesia and delirium (CAM-ICU) screening. On propofol, watch the blood pressure closely on any rate change, monitor triglycerides and CK on prolonged high-dose runs, and keep the PRIS picture in mind. On midazolam, anticipate a delayed wake-up — especially with renal/hepatic dysfunction — and screen aggressively for delirium. Flumazenil can reverse a benzodiazepine but is used with great caution because it can precipitate seizures, particularly in chronic benzo users. Titrate to the lightest effective sedation in both cases; deeper is not safer.
Related: Propofol deep dive · Midazolam (Versed) · Precedex vs propofol · ICU sedation & analgesia
Get the ICU Notebook
Free investing strategies built for nurses. One email per week, no fluff.
Yes, send it freeNo spam. Unsubscribe any time.